Push to name doctors with pharma links

Australia's competition watchdog is under pressure to rethink its plans to approve the latest draft code of conduct for the pharmaceutical industry, with critics saying the code should force companies to disclose payments to individual doctors.

A petition signed by about 300 doctors, researchers and consumers calls for major changes to Medicines Australia’s draft code of conduct, which has been